Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

A novel coronavirus 3cl protease inhibitor based on the structure of menadione

A technology of coronavirus and menadione, which is applied in the field of medicine, can solve the problems of strong toxicity and limited clinical application, and achieve the effects of low toxicity, easy availability of raw materials, and strong growth inhibitory activity

Active Publication Date: 2022-04-26
SHANGHAI JIAOTONG UNIV
View PDF5 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

However, some novel coronavirus 3CL protease inhibitors, including shikonin and juglone, have a naphthoquinone structure in their molecular structure, exhibit strong toxicity, and have a certain killing effect on normal host cells; this defect , limiting the clinical application of shikonin, juglone and other compounds as anti-new coronavirus drugs

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • A novel coronavirus 3cl protease inhibitor based on the structure of menadione
  • A novel coronavirus 3cl protease inhibitor based on the structure of menadione
  • A novel coronavirus 3cl protease inhibitor based on the structure of menadione

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0035] This embodiment relates to a preparation method of 2-methyl-1,4-naphthoquinone (II-1) having structural formula (II), comprising the following steps:

[0036]

[0037] At room temperature, 14.2g of 2-methylnaphthalene (100mmol) was dissolved in glacial acetic acid (50mL), and this solution was added dropwise to 200 ml of glacial acetic acid solution of 58.7 grams of chromic anhydride. Maintain at 35-40°C. After the addition, keep it at 40°C for 0.5 hours, raise the temperature to 65°C and keep it for 20 minutes; pour the reactant into a large amount of ice water, and precipitate the crude 2-methyl-1,4-naphthoquinone under constant stirring. Filter the crude product, and wash the filter cake repeatedly with ice water until the filtrate has no sour taste. The filter cake was dissolved with dichloromethane, and after the organic layer was separated, a small amount of activated carbon was added for decolorization. The dichloromethane was distilled off under reduced pre...

Embodiment 2

[0039] This example relates to a preparation method of 2-acetyl-8-methoxy-1,4-naphthoquinone (III-1) having the structural formula (III), comprising the following steps:

[0040]

[0041] Using the reported method (Zhang et al.Synthesis of 4,8-dimethoxy-1-naphtholvia an acetyl migration.Synth.Commun.,2017,47(6),536-540), using juglone as raw material, synthesize 4 ,8-Dimethoxy-1-naphthol acetate. Dissolve 4,8-dimethoxy-1-naphthol acetate (300mg, 1.22mmol) in boron trifluoride-ether solution (5mL, boron trifluoride content is 48%), and the reaction solution The temperature was raised to 60°C and the reaction was stirred at this temperature for 30 minutes. The reaction solution was cooled and diluted with ice water, extracted with dichloromethane, the organic layer was dried and concentrated to dryness under reduced pressure, and the residue was purified by column chromatography to obtain 2-acetyl-4,8-dimethoxy-1- Naphthol, light yellow powder, about 237mg, yield: 79%. 1 H...

Embodiment 3

[0043] This embodiment relates to a preparation method of 2-hydroxy-1,4-naphthoquinone (IV-1) having structural formula (IV), comprising the following steps:

[0044]

[0045] 1,4-Naphthoquinone (3.16 g, 20 mmol) was dissolved in acetic anhydride (20 mL), and 4 drops of concentrated sulfuric acid were added dropwise. The mixture was stirred and reacted in an ice-water bath for 8 hours. The reaction solution was filtered with suction, and the filter cake was washed with petroleum ether and a small amount of pre-cooled absolute ethanol to obtain about 4.72 g of off-white powder. The powder was dissolved in methanol, and 0.5 g of sodium methoxide was added under an ice-water bath. After the mixture was stirred and reacted in an ice-water bath for 4 hours, it was suction-filtered, and the red filter cake was collected and washed with a small amount of methanol. Dissolve the above filter cake in water at 90°C, and suction filter it while it is hot; acidify the filtrate with con...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention discloses a menaquinone derivative against novel coronavirus and its medical application; the structure of the compound is shown in formula (I): wherein, R is a hydrogen atom, a methyl group, an acetyl group or a hydroxyl group, and R is 1 is a hydrogen, methoxy, benzyloxy or benzoyloxy group. The compound disclosed in the present invention can inhibit the 3CL hydrolase of 2019-nCoV novel coronavirus, and has anti-novel coronavirus activity. In vitro activity assays showed that some compounds had an enzyme inhibition rate of more than 90% at a concentration of 1 μM, which was significantly better than the positive control drug shikonin. The results of the toxicity test at the cellular level show that the toxicity of the menadione and its derivatives of the present invention to the host normal cell HSF cells is significantly lower than that of the positive drugs shikonin and juglone, and some compounds have shown strong anti-toxicity in vitro. The activity of the new coronavirus is of great significance to the development of new anti-new coronavirus drugs with high efficiency and low toxicity.

Description

technical field [0001] The invention belongs to the field of medicine, and relates to a novel coronavirus 3CL protease inhibitor based on the structure of menadione; more specifically, it relates to a menadione derivative and its use in the preparation of anti-new coronavirus 2019-nCoV drugs. use. Background technique [0002] The 2019 novel coronavirus (2019-nCoV) is an enveloped, positive-sense, single-stranded RNA coronavirus that has caused acute viral pneumonia that has recently spread worldwide (Zhou et al.2020.A pneumonia ou tbreakassociated with a new coronavirus of probable bat origin. Nature, 57 9: 270-273.). Viruses are non-cellular microorganisms, mainly composed of external proteins and internal nucleic acids, lacking an independent metabolic structure, and can only parasitize in host cells, using host cell proteins and nucleic acids as necessary substances for their survival and reproduction. Viruses replicate nucleic acids in host cells, synthesize proteins,...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Patents(China)
IPC IPC(8): C07C50/12C07C50/32A61P31/14
CPCC07C50/12C07C50/32A61P31/14
Inventor 崔家华贾金平
Owner SHANGHAI JIAOTONG UNIV
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com